This Bylaw was adopted as a re-sult of the process of harmonization of the national regulation in thattime in accordance with existing European "soft" legislation.The implementation of this Bylaw so far showed the need for furtheramendment, respectively - changing the existing classification of thevariations, parallel with the legal procedures, all in goal to improve theprocedures and for continuous supervision of the medicinal products.The objective of the new Bylaw on variations of marketing authoriza-tions for medicinal products in the Republic of Macedonia is to im-prove some particular solutions for the classification of variations andthe manner of their notification or approval and implementation ofgiven variation. This review arises from the continuous following theEuropean Commission regulations and transposing them accordingly.The new Bylaw on variations proposes simplified, clear and more flex-ible legal framework that guarantees the same level of public healthcare protection. The adjusted procedures laid down in the Bylaw areadapted without departing from the general principles on which thoseprocedures are based. The variations are classified in different cate-gories, depending on the level of risk to public health and the impacton the quality, safety and efficacy of the medicinal product concerned.Definitions for each of those categories and details of the conditionsfor classification of the various categories of variations are regularlyupdated in the Bylaw; they assist foresight and follow the basic guide-lines with the details for various categories of variations that are in-tegral parts of the Regulation (EC) No. 1234/08 of the Commission ofthe European Parliament and Council. Certain changes which have thehighest potential impact on the quality, safety or efficiency of medic-inal products require a complete scientific assessment, in the sameway as for the evaluation of the new marketing authorisation appli-cations.In order to further reduce the overall number of procedures for varia-tions and to enable focusing on those variations that have a genuineimpact on the quality, safety and efficiency of the medicinal products,a system of annual reporting for certain minor variations has been in-troduced. Procedure "do and tell" is set-out for such minor variationsthat do not require any prior approval before implementation and theyneed to be notified within 12 months following their implementation.Other types of minor variations whose immediate reporting is neces-sary for the continuous supervision of the medicinal product are notsubject of the annual reporting system.Each variation requires a separate single submission. In order to facil-itate the review of the variations and reduce the administrative bur-87PHARMACEUTICAL ANALYSIS / QUALITY ASSURANCE / REGULATORY AFFAIRS poster presentationsFIFTH CONGRESS OF PHARMACY OF MACEDONIA WITH INTERNATIONAL PARTICIPATIONMacedonian Pharmaceutical Bulletin 57 (suppl), 2011den, grouping the variations is allowed in certain cases, accordingly tothe directions provided. Single submission with grouping of variationscovers all such variations that fall within one of the allowed cases orhave agreement with authority to be in the same procedure.Grouping of variations can be accepted only in cases when the samegroup of minor changes are affected in the same time in one or moremedicinal products of the same marketing authorisation holder and incases when multiple variations are introduced within one medicinalproduct at the same time according to determined directions or afterprior consent by the Agency that all stated variations can be includedin a single procedure.The new Bylaw explains when the holder of marketing authorization isallowed to implement the given variation and from an economic as-pect it is of essential importance for each producer.The aim of the new Bylaw on variations is to unify the classification ofthe variations, to provide continuous supervision of the medicinalproduct, to adjust the legal procedures and to define their time dura-tion, to clarify when the holder of marketing authorisation has been al-lowed to implement the variations and to achieve maximum level ofharmonization with the latest EU regulation.The different categories of variations introduced by this Bylaw shouldbe regularly updated in the light of scientific and technical progress,taking into account the particular importance of the harmonizationon international level.REFERENCESBylaw on variations to a marketing authorization for a medicinal product or to theapproved documentation of a medicinal product with a marketing authorization(,,Official Gazette of the Republic of Macedonia" No.62/11 since 05 May 2011)Commission Regulation (EC) No 1234/2008 of 24 November 2008 concerning theexamination of variations to the terms of marketing authorization for medicinalproducts for human use and veterinary medicinal productsPost-authorization procedural advice on variation regulation (EC) No 1234/2008,Human Medicinal ProductsCommission - Guideline on the details of various categories of variations to theterms of marketing authorization for medicinal products for human use andveterinary medicinal productsNOVA REGULATIVA ZA VARIJATsII NAODOBRENIE ZA STAVANjE NA LEK VOPROMET VO REPUBLIKA MAKEDONIJA,KhARMONIZATsIJA SO EUVesna Nasteska-Nedanovska, Ilcho Zakhariev,Marija Trajchuleski, Rajna KostoskaBiro za lekovi pri Ministerstvo za zdravstvo na Republika Ma kedo nijaVo Pravilnikot za varijatsii na vekje dobieno odobrenie zastavanje na lek vo promet (,,Sluzhben vesnik na RepublikaMakedonija", br. 145/08) sodrzhani se osnovnite nasoki zaklasifikatsija na varijatsiite, uslovite shto treba da bidatispolneti, legalnite postapki shto se vodat za prijavuvanje/odobruvanje na promenite, kako i za nachinot na nivnotovoveduvanje. Donesuvanjeto na ovoj pravilnik proizle gu vashe odusoglasuvanje na ovaa materija so Evropskoto ,,soft" zakonodavstvo. Dosegashnata primena na ovoj pravilnik pokazha deka ima potrebaod natamoshno dograduvanje, odnosno menuvanje na postojnataklasifikatsija na varijatsiite, no istovremeno i na legalnitepostapki, zaradi podobruvanje na kvalitetot na istite i podobrosledenje na lekot. Noviot pravilnik za varijatsii vo RepublikaMakedonija e vo funktsija na podobruvanje na oddelni reshenija voklasifikatsijata na varijatsiite i nachinot na nivnoto prijavuvanje ivoveduvanje, a koi proizleguvaat od kontinuiranoto sledenje naregulativite na Evropskata komisija i nivno soodvetno transpo ni -ranje.So noviot pravilnik za varijatsii se predlagaat ednostavni, jasnii povekje fleksibilni legalni reshenija shto garantiraat iststepen na zdravstvena zashtita kaj lugjeto. Postapkite zaprijavuvanje na varijatsiite se prilagodeni bez da se otstapi odgeneralnite printsipi na koi tie se baziraat. Varijatsiite seklasifitsirani vo razlichni kategorii vo zavisnost od rizikot pozdravjeto na lugjeto i nivnoto potentsijalno vlijanie na kvalitetot,bezbednosta i efikasnosta na lekot. Nasokite i uslovite zaklasifikatsija na varijatsiite se regulatorno azhurirani, japotpomagaat predv id li vosta i gi sledat osnovnite napatstvija sopodrobnostite za razlichnite kategorii na varijatsii shto sesostaven del na Regulativata (EZ) br. 1234/08 na Komisijata naEvropskiot parlament i Sovet. Sekako deka odredeni promeni koishto imaat najgolemo potentsijalno vlijanie na kvalitetot,bezbednosta i efikasnosta na lekot i baraat tselosna nauchnaprotsenka, dobivaat ist nachin na evaluatsija kako i novo baranje zamarketing av to ri za tsi ja.So tsel da se namali preobemniot broj na postapki za varijatsii ida se postigne fokusiranje na onie varijatsii koi shto imaatznachitelno vlijanie na kvalitetot, bezbednosta i efikasnosta nalekot, prifaten e sistem na godishno izvestuvanje za odredeni malipromeni. Za mali varijatsii koi shto ne baraat pretkhodnoodobruvanje se voveduva postapa ,,do and tell,, i istite se podnesuvaatvo rok od 12 mesetsi posle nivnoto voveduvanje. Odredeni malipromeni treba vednash da se notifitsiraat posle nivnotovoveduvanje, so tsel da se obezbedi kontinuirano sledenje na lekoti tie ne se predmet na godishno izvestuvanje (immediate notification).Vo edna postapka mozhe da se podnese poedinechno baranje za sekojaoddelna varijatsija. Za da se postigne preglednost na varijatsiite,a so tsel da se namali administrativniot tovar, sozdadena e osnova88Makedonski farmatsevtski bilten 57 (dodatok), 2011FARMATsEVTSKI ANALIZI / OBEZBEDUVANjE KVALITET / REGULATIVA poster prezentatsiiPETTI KONGRES NA FARMATsIJATA SO MEGjUNARODNO UChESTVOza grupiranje na varijatsiite na eden obrazets na baranje shto edozvoleno samo vo odredeni sluchai, spored dadeni nasoki.Grupiranje na varijatsiite mozhe da se prifati samo vo sluchai kogaista grupa na mali promeni se voveduvaat vo isto vreme kaj edenili povekje lekovi na eden ist nositel na odobrenijata za stavanjevo promet i vo sluchai koga povekje varijatsii se voveduvaat kaj edenlek vo isto vreme spored utvrdeni nasoki ili po pretkhodnasoglasnost na Agentsijata deka site navedeni varijatsii mozhat dase vkluchat vo edna ista postapka.Pravilnikot objasnuva koga na nositelot na odobrenieto mu edopushteno da ja vovede dadenata varija, a toa e od sushtinskavazhnost za sekoj proizvoditel od ekonomski aspekt.Tselta shto treba da se postigne so noviot pravilnik za varijatsiie unifitsiranje na klasifikatsijata na varijatsiite, obezbeduvanjena kontinuirano sledenje na lekot, usoglasuvanje na legalnitepostapki i ureduvanje na rokovite za istite, voveduvanje navarijatsiite i maksimalna kharmonizatsija so regulativata na EU.Razlichnite kategorii na varijatsii shto se vovedeni so ovojpravilnik treba i vo idnina redovno da se azhuriraat vosoglasnost so nauchniot i tekhnichkiot razvoj, zemajkji go posebnoznachenjeto na internatsionalnata kharmonizatsija. KORISTENA LITERATURAPravilnik za varijatsii na odobrenieto za stavanje na lek vo promet ili naprifatenata dokumentatsija na lek shto ima dobieno odobrenie za stavanje vopromet (,,Sluzhben Vesnik na RM" br.62/11 od 05 maj 2011 godina)Commission Regulation (EC) No 1234/2008 of 24 November 2008 concerning theexamination of variations to the terms of marketing authorization for medicinalproducts for human use and veterinary medicinal productsPost-authorization procedural advice on variation regulation (EC) No 1234/2008,Human Medicinal ProductsCommission - Guideline on the details of various categories of variations to theterms of marketing authorization for medicinal products for human use andveterinary medicinal productsCLASSIFICATION OF MEDICINES AS RE-GARDS THEIR SUPPLY, PREREQUSIT FORPUBLIC HEALTH PROTECTIONMerjem Hadjihamza Ministry of Health, Republic of MacedoniaClassification of medicines as regards their supply is the competencyof Health authorities of each country and is of particular importancefor the preservation of public health. We live in times when enormousfinancial resources are invested in pharmaceutical industry, whichmeans development of new medicines that represent advancementin pharmacotherapy, thus proper selection and classification of thesemedicines is of strategic importance for each country especially forthose in transition. Legal classification of medicines as regards theirsupply with or without medical prescription has implications onpatient safety, the accessibility of medicines to patients and also atthe responsible management of health care expenditure.Considering the broader accessibility of medicines and the necessityof introducing harmonized provisions and conditions favoring the safeuse of prescription and nonprescription medicines, On April 2007Committee of ministers, member states of the Partial Agreement inSocial and Public Health Field, adopted the Resolution ResAP(2007)1on Classification of Medicines as regards their supply. Council of Europe Committee of Ministers Resolution ResAP (2007)1on the classification of medicines as regards their supply >> Recommends to the governments of the member states of thePartial Agreement in theSocial and Public Health Field that they supply information on thenational legal classification of medicines as regards their supply on aregular basis;>> Recommends to the same governments that they apply thegeneral provisions and theClassification of active substances depending on the supply conditionsof the medicines which contain them, as set out in the appendices ofthe Resolution ResAP(2007)1>> Recommends to the same governments that they adopt thegeneral provisions relating toMinimum information to be included in prescriptions;These recommendations are not legally binding but they are legalinstruments and contain a political statement. There is a Committee of Experts on classification of medicines asregards their supply which is coordinated by the European Directoratefor Quality of Medicines & HealthCare (EDQM), Council of Europe. ThisCommittee at its work uses scientific approaches and methods takingaccount of medicines' pharmacological properties, issues relating todirect and indirect risks (pharmacovigilance) as well as miss/abuse,matters of public health concern. It gives annual recommendationson classification of medicines as regards their supply which can befound at the web site of EDQM. Although this recommendations arenot legally binding the may be used as a relevant reference to themember states and broader. It is evident that classification practices differ from Country toCountry and harmonization in this field would be preferred especiallyfor over the counter medicines.Having in mind all above mentioned it may be concluded that thecurrent regulative (Law on medicines and medical devices -article 13and the Rulebook on the manner of prescribing and dispensingmedicinal products on prescription) regarding classification ofmedicines in Republic of Macedonia do comply with EuropeanDirectives. The Rulebook allou us to also implement therecommendations and provisions set up at the appendices ofResolution ResAP(2007)1 on the classification of medicines as regardstheir supply. REFERENCES1. Resolution ResAP(2007)1 on the classification of medicines as regards theirsupply2. Law on medicinal products and medical devices(www.reglek.com.mk)3. Rulebook on the manner of prescribing and dispensing medicinal products onprescription(http://www.reglek.com.mk)89PHARMACEUTICAL ANALYSIS / QUALITY ASSURANCE / REGULATORY AFFAIRS poster presentationsFIFTH CONGRESS OF PHARMACY OF MACEDONIA WITH INTERNATIONAL PARTICIPATIONMacedonian Pharmaceutical Bulletin 57 (suppl), 2011KLASIFIKATsIJATA NA LEKOVITESPORED NAChINOT NA IZDAVANjEPREDUSLOV ZA ZAChUVUVANjE NAJAVNOTO ZDRAVJEMerjem Khadzhikhamza Ministerstvo za Zdravstvo, Republika MakedonijaKlasifikatsijata na lekovite spored nachinot na izdavanjepretstavuva obvrska na zdravstvenite avtoriteti odnosno nanatsionalnite tela vo ramkite na zdravstveniot sistem na sekojazemja i e od osobena vazhnost za zachuvuvanje na javnoto zdravje.Zhiveeme vo vreme koga enormni finasiski sredstva seinvestiraat vo farmatsevtskata industrija shto rezultira soproizvodstvo na se pogolem broj novi lekovi koi pretstavuvaatunapreduvanje vo farmakoterapijata no sepak za sekoja zemja aposebno za zemjite vo tranzitsija iskluchitelno vazhno i odstrateshko znachenje e pravilnata selektsija na tie lekovi isoodvetniot nachin na propishuvanje i izdavanje.